Micro-X Limited Stock: price and insider trades · Australia

Micro-X Limited, classified in the Health Care sector, is a listed company. Its insiders report their share dealings to ASX. The last twelve months, up to 18 October 2026, brought 10 filings signed by 8 insiders.

Every open-market trade in the period is a purchase: 6 purchases worth €773k, from 4 insiders, and not a single sale. No amount is published for 1 filing, which the totals therefore leave out. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Those buying include 4 senior executives. At €310k, the purchase published on 9 October 2026 by Patrick O’Brien is the largest of the period (1.0% of market cap).

In the case of 3 purchases, another manager of the company was buying within the same 30 days. A cluster is several different insiders buying the same stock within a short window, a pattern studied more closely than a single purchase. The latest purchase is recent: it was published 9 days ago, on 9 October 2026. Half of the filings or more reach the ASX feed on the day of the trade. The shorter that gap, the sooner other investors can see what insiders have done.

Across the 2,526 companies tracked on its exchange, the median is 3 filings; at 10 filings, this issuer sits above that mark. Our records for Micro-X Limited go back to 2026, with 6 purchases and no sales on the open market in total.

For comparison within the same sector, see the insider buying recorded at Cooper Companies, Inc. and Cytosorbents Corp. Source: insider filings from ASX. Past trades are no guide to future returns.